Dynamic Tests in Pituitary Endocrinology: Pitfalls in Interpretation during Aging.


Journal

Neuroendocrinology
ISSN: 1423-0194
Titre abrégé: Neuroendocrinology
Pays: Switzerland
ID NLM: 0035665

Informations de publication

Date de publication:
2022
Historique:
received: 09 11 2020
accepted: 12 01 2021
pubmed: 18 1 2021
medline: 22 2 2022
entrez: 17 1 2021
Statut: ppublish

Résumé

Aging and age-related diseases represent hot topics of current research. Progressive damage in morphology and function of cells and tissue characterizes the normal process of aging that is influenced by both genetic and environmental factors. The ability of each individual to adapt to these stressors defines the type of aging and the onset of age-related diseases (i.e., metabolic syndrome, inflammatory disorders, cancer, and neurodegenerative diseases). The endocrine system plays a critical role in this process because of its complex relationships with brain, immune system, and skeletal muscle; thus, alterations in hormonal networks occur during aging to maintain homeostasis, with consequent under- or overactivity of specific hypothalamic-pituitary-peripheral hormone axes. On the other hand, the increase in life expectancy has led to increasing incidence of age-related diseases, including endocrine disorders, which may prompt assessment of endocrine function in aging individuals. In this context, there is growing awareness that natural changes of endocrine physiology and physiopathology occurring with increasing age may necessitate age-driven diagnostic cutoffs requiring validation in the elderly. This review aims to analyze the available literature on the hormone response to the most important dynamic tests currently used in the clinical practice for the screening of anterior pituitary-related diseases to underline pitfalls in interpretation during aging.

Identifiants

pubmed: 33454712
pii: 000514434
doi: 10.1159/000514434
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-14

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Marina Caputo (M)

Endocrinology, Department of Translational Medicine, University of Piemonte Orientale (UPO), Novara, Italy, marina.caputo@uniupo.it.
Department of Health Sciences, University of Piemonte Orientale (UPO), Novara, Italy, marina.caputo@uniupo.it.

Chiara Mele (C)

Endocrinology, Department of Translational Medicine, University of Piemonte Orientale (UPO), Novara, Italy.

Alice Ferrero (A)

Endocrinology, Department of Translational Medicine, University of Piemonte Orientale (UPO), Novara, Italy.

Ilaria Leone (I)

Endocrinology, Department of Translational Medicine, University of Piemonte Orientale (UPO), Novara, Italy.

Tommaso Daffara (T)

Endocrinology, Department of Translational Medicine, University of Piemonte Orientale (UPO), Novara, Italy.

Paolo Marzullo (P)

Endocrinology, Department of Translational Medicine, University of Piemonte Orientale (UPO), Novara, Italy.
IRCCS Istituto Auxologico Italiano, Laboratory of Metabolic Research, Novara/Milan, Italy.

Flavia Prodam (F)

Endocrinology, Department of Translational Medicine, University of Piemonte Orientale (UPO), Novara, Italy.
Department of Health Sciences, University of Piemonte Orientale (UPO), Novara, Italy.

Gianluca Aimaretti (G)

Endocrinology, Department of Translational Medicine, University of Piemonte Orientale (UPO), Novara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH